Zygel
-
Devon’s Zynerba Secured in $2 Million Deal by Harmony Biosciences
Devon-based Zynerba is set to be acquired by Harmony Biosciences Holdings in a $2 million deal, writes John George for the Philadelphia Business Journal. …
-
Devon-Based CBD Developer Plans Reverse Stock Split
A Devon pharmaceutical company is working on cannabinoid therapies to treat genetic conditions. In the meantime, Zynerba Pharmaceuticals is planning a reverse stock split by…
-
This Devon-Based Pharmaceutical Company Aims to Treat Autism with CBD
Zynerba Pharmaceuticals, a clinical-stage pharmaceutical company based in Devon, is testing a CBD gel to help treat autism, writes Queen Muse for Philadelphia magazine. The…
-
Shares of Devon-Based Zynerba Pharmaceuticals Surge After Firm Wins Patent
Devon-based Zynerba Pharmaceuticals saw its shares surge after it received a U.S. patent for its cannabidiol (CBD) gel to treat Autism Spectrum Disorders, writes Sam…
-
Synthetic Cannabidiol Drug from Devon-Based Zynerba Pharmaceuticals Now on the ‘Fast Track’
Devon-based Zynerba Pharmaceuticals has received “Fast Track” status from the FDA for its synthetic cannabidiol drug intended to treat symptoms associated with Fragile X, writes…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
